Medicus Pharma starts genomic endometriosis trial in UAE

June 11, 2026 7:30 AM

Medicus Pharma Ltd. (NASDAQ: MDCX) submitted an Investigational New Drug application to the Department of Health, Abu Dhabi for PRECISION-E2 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found